Clinical trial
Use of FERAHEME® (Ferumoxytol) for Severe Chronic Kidney Disease and Peritoneal Dialysis
NCT01942460 is registered in ClinicalTrials.gov with Georges Ouellet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of FERAHEME® (Ferumoxytol) for Severe Chronic Kidney Disease and Peritoneal Dialysis
- Lead sponsor
- Georges Ouellet
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- June 30, 2014
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammation, iron-deficiency anemia, oxidative stress